CAS No. |
2651994-75-9 |
|---|---|
英文名称 |
CypD-IN-3 |
别名 |
[(4'-{[(4S,7S,11R,13E,19S)-19-{[2-(2-aminoethoxy)ethyl]carbamoyl}-7-benzyl-3,6,12,15,21-pentaoxo-1,3,4,5,6,7,8,9,10,12,15,16,17,18,19,20,21,22-octadecahydro-2H-7,11-methano-2,5,11,16,20-benzopentaazacyclotetracosin-4-yl]methyl}[1,1'-biphenyl]-4-yl)methyl]propanedioic acid;2-((4'-(((13S,4S,12S,E)-12-((2-(2-aminoethoxy)ethyl)carbamoyl)-13-benzyl-2,5,10,16,19-pentaoxo-3,6,11,15-tetraaza-1(3,1)-piperidina-8(1,2)-benzenacyclononadecaphan-17-en-4-yl)methyl)-[1,1'-biphenyl]-4-yl)methyl)malonic acid;2-[[4-[4-[[(1S,4S,17S,22E)-17-[2-(2-aminoethoxy)ethylcarbamoyl]-1-benzyl-2,5,15,21,24-pentaoxo-3,6,16,20,25-pentazatricyclo[23.3.1.08,13]nonacosa-8,10,12,22-tetraen-4-yl]methyl]phenyl]phenyl]methyl]propanedioic acid;CypD inhibitor B52;CypD-IN-3 |
标准英文名 |
2-((4'-(((13S,4S,12S,E)-12-((2-(2-aminoethoxy)ethyl)carbamoyl)-13-benzyl-2,5,10,16,19-pentaoxo-3,6,11,15-tetraaza-1(3,1)-piperidina-8(1,2)-benzenacyclononadecaphan-17-en-4-yl)methyl)-[1,1'-biphenyl]-4-yl)methyl)malonic acid |
分子式 |
C53H61N7O11 |
分子量 |
972.11 |
精确分子量 |
971.44 |
SMILES |
O=C(/C=C/C(NCC[C@H](NC(CC1=CC=CC=C1CNC([C@@H](NC2=O)CC3=CC=C(C4=CC=C(C=C4)CC(C(O)=O)C(O)=O)C=C3)=O)=O)C(NCCOCCN)=O)=O)N(CCC5)C[C@@]52CC6=CC=CC=C6 |
标准SMILES |
NCCOCCNC(=O)[C@@H]1CCNC(=O)C=CC(=O)N2C[C@@](CC3C=CC=CC=3)(CCC2)C(=O)N[C@@H](CC2C=CC(=CC=2)C2C=CC(CC(C(O)=O)C(O)=O)=CC=2)C(=O)NCC2=CC=CC=C2CC(=O)N1 |
用途 |
CypD-IN-3 is a potent and subtype-selective cyclophilin D (CypD) inhibitor with an IC50 value of 0.01 μM; it can be used in the research of various diseases, including oxidative stress, neurodegenerative diseases, liver diseases, aging, autophagy, and diabetes. |
InChIKey |
ZHNYUSCORILKFS-FCZRSVTRSA-N |
|
|
评论 |
|---|